Bernadette E Vitola

The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration

F. Gottrand, T. Miloh, B. Kamath, 2017, Hepatology.

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis

T. Miloh, N. Kerkar, S. Guthery, 2020, Hepatology.

The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children

T. Miloh, N. Kerkar, S. Guthery, 2020, Hepatology.

Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium

T. Miloh, Amy E Taylor, A. Montano‐Loza, 2020, Journal of pediatric gastroenterology and nutrition.

Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.

B. S. Mohammed, S. Klein, E. Kirk, 2008, The American journal of clinical nutrition.

Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis

F. Gottrand, T. Miloh, A. Tanaka, 2018, Hepatology communications.

Weight Loss Reduces Liver Fat and Improves Hepatic and Skeletal Muscle Insulin Sensitivity in Obese Adolescents

B. S. Mohammed, S. Klein, E. Kirk, 2009, Obesity.

Alterations in Fatty Acid Kinetics in Obese Adolescents With Increased Intrahepatic Triglyceride Content

B. S. Mohammed, S. Klein, E. Fabbrini, 2009, Obesity.

COVID-19 Disease in Pediatric Solid Organ Transplantation from Alpha to Omicron: A High Monocyte Count in the Preceding Three Months Portends a Risk for Severe Disease

T. Fishbein, A. Kroemer, U. Ekong, 2023, Viruses.